Martin Currie’s Pfizer PFE Stock Holding History

Martin Currie’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,184	Closed	-$625K	–	68
2020 Q1	$625K	Hold	20,184	–	–	0.04%	53
2019 Q4	$750K	Hold	20,184	–	–	0.04%	56
2019 Q3	$688K	Hold	20,184	–	–	0.04%	67
2019 Q2	$830K	Hold	20,184	–	–	0.06%	64
2019 Q1	$813K	Hold	20,184	–	–	0.06%	68
2018 Q4	$836K	Sell	20,184 -83,062	-80%	-$3.45M	0.07%	69
2018 Q3	$4.32M	Sell	103,246 -180,061	-64%	-$6.93M	0.3%	66
2018 Q2	$9.75M	Hold	283,307	–	–	0.68%	41
2018 Q1	$9.54M	Hold	283,307	–	–	0.66%	44
2017 Q4	$9.74M	Sell	283,307 -59,639	-17%	-$2.03M	0.69%	40
2017 Q3	$11.6M	Sell	342,946 -9,507	-3%	-$306K	0.89%	36
2017 Q2	$11.2M	Sell	352,453 -193,943	-35%	-$6.12M	0.9%	37
2017 Q1	$17.7M	Sell	546,396 -33,622	-6%	-$1.06M	1.46%	18
2016 Q4	$17.9M	Sell	580,018 -118,786	-17%	-$3.63M	1.67%	15
2016 Q3	$22.5M	Sell	698,804 -111,935	-14%	-$3.74M	2.03%	9
2016 Q2	$27.1M	Sell	810,739 -73,790	-8%	-$2.36M	2.61%	7
2016 Q1	$24.9M	Sell	884,529 -7,378	-0.8%	-$211K	2.37%	9
2015 Q4	$27.3M	Sell	891,907 -4,322	-0.5%	-$136K	2.76%	5
2015 Q3	$26.7M	Sell	896,229 -55,124	-6%	-$1.77M	2.76%	6
2015 Q2	$30.3M	Sell	951,353 -21,818	-2%	-$711K	2.89%	8
2015 Q1	$32.1M	Sell	973,171 -143,133	-13%	-$4.55M	2.87%	8
2014 Q4	$33M	Buy	1,116,304 +8,537	+0.8%	+$245K	2.83%	7
2014 Q3	$31.1M	Sell	1,107,767 -166,532	-13%	-$4.67M	2.67%	9
2014 Q2	$35.9M	Sell	1,274,299 -173,066	-12%	-$4.93M	3.11%	9
2014 Q1	$44.1M	Sell	1,447,365 -71,251	-5%	-$2.12M	4.05%	4
2013 Q4	$44.1M	Buy	1,518,616 +84,847	+6%	+$2.47M	4.05%	3
2013 Q3	$39.1M	Sell	1,433,769 -7,589	-0.5%	-$206K	4.2%	2
2013 Q2	$38.3M	Buy	+1,441,358	New	+$39.8M	4.16%	3

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Martin Currie's PFE Position: Q2 2020 in Review

Martin Currie sold out of Pfizer (PFE) in Q2 2020, closing a stake of 20,184 shares — an estimated $625K sold.

Martin Currie first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $44.1M in Q4 2013. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Martin Currie reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Martin Currie sold 20,184 Pfizer shares in Q2 2020, an estimated $625K.
Martin Currie first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
Martin Currie's Pfizer position peaked at $44.1M in Q4 2013.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Martin Currie's 13F filing for Q2 2020, filed 14 Aug 2020.